HomeERNA • NASDAQ
Ernexa Therapeutics Inc
add
$2.63
3.95%
After Hours:(0.76%)+0.020
$2.65
Closed: Jun 18, 7:29:48 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | -52.71% |
Net income | -8.20M | -23.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.71M | 52.82% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92M | -62.51% |
Total assets | 5.06M | -89.81% |
Total liabilities | 11.01M | -79.26% |
Total equity | -5.95M | — |
Shares outstanding | 4.16M | — |
Price to book | -1.48 | — |
Return on assets | -132.16% | — |
Return on capital | 1,998.54% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.20M | -23.39% |
Cash from operations | -2.07M | 44.89% |
Cash from investing | — | — |
Cash from financing | 2.25M | 62.74% |
Net change in cash | 189.00K | 107.69% |
Free cash flow | 4.44M | 410.81% |
Previous close
$2.53
Day range
$2.36 - $2.65
Year range
$2.09 - $39.38
Market cap
19.36M USD
Avg Volume
52.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
6
